🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prevalence of Long COVID-19 in the Canary Islands

Recruitingn/aAges 18 Years - anyAllUniversity of Las Palmas de Gran Canaria
NCT05228691 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

With more than 246 million people diagnosed with coronavirus 2019 (COVID-19) around the world, many of whom have required medical attention for past 23 months, greater emphasis is being placed on post-acute care of COVID-19 survivors. According to recent data, millions of patients who have recovered from acute COVID-19 are experiencing persistent symptoms, which lead to disability and impaired activities of daily living. Various terms have been used to describe the condition of patients who do not return to their initial health status to include post-acute sequelae of COVID-19, such as post-acute COVID syndrome (PACS) and Long COVID. The growing global burden of COVID-19 suggests that the potential effects of Long COVID in public health are vast even if Long COVID is experienced by a small proportion of patients recovering from acute infection. The ability to identify patients at high

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Have been positive for COVID-19 since the declaration of the state of alarm throughout the Spanish territory to deal with the health emergency situation caused by COVID-19 (March 14, 2020). * Symptoms associated with COVID-19 at least after 12 weeks of its detection. * Adequate cognitive and physical level to understand and perform the tests evaluation. Exclusion Criteria: * Present comorbidities prior to suffering from COVID-19 whose symptoms are resemble Post-acute COVID-19. * Fibromyalgia. * Chronic fatigue. * Neuromuscular disease. * Not having signed the informed consent. * Person undergoing treatment for active cancer.
💊

What it tests

  • Evaluation and Education
📍

Where

1 site
University of Las Palmas de Gran Canaria
Las Palmas de Gran Canaria, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy